KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $3.1 billion.

  • Amgen's Other Operating Expenses fell 381.34% to $3.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.3 billion, marking a year-over-year increase of 185.41%. This contributed to the annual value of $13.3 billion for FY2025, which is 185.41% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Other Operating Expenses is $3.1 billion, which was down 381.34% from $3.4 billion recorded in Q3 2025.
  • Amgen's 5-year Other Operating Expenses high stood at $3.8 billion for Q1 2025, and its period low was $1.6 billion during Q1 2021.
  • In the last 5 years, Amgen's Other Operating Expenses had a median value of $2.8 billion in 2023 and averaged $2.5 billion.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 9901.48% in 2021, then tumbled by 3650.99% in 2022.
  • Amgen's Other Operating Expenses (Quarter) stood at $1.8 billion in 2021, then decreased by 3.17% to $1.7 billion in 2022, then soared by 81.96% to $3.1 billion in 2023, then rose by 1.8% to $3.2 billion in 2024, then decreased by 3.81% to $3.1 billion in 2025.
  • Its Other Operating Expenses was $3.1 billion in Q4 2025, compared to $3.4 billion in Q3 2025 and $3.1 billion in Q2 2025.